Antibiotic therapy may improve idiopathic restless legs syndrome: Prospective, open-label pilot study of rifaximin, a nonsystemic antibiotic

被引:8
作者
Weinstock, Leonard B. [1 ]
机构
[1] Washington Univ, Sch Med, St Louis, MO 63141 USA
关键词
INTESTINAL BACTERIAL OVERGROWTH; IRRITABLE-BOWEL-SYNDROME;
D O I
10.1016/j.sleep.2009.06.005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:427 / 427
页数:1
相关论文
共 5 条
[1]   Rifaximin treatment for symptoms of irritable bowel syndrome [J].
Fumi, Andrea L. ;
Trexler, Katherine .
ANNALS OF PHARMACOTHERAPY, 2008, 42 (03) :408-412
[2]   Small intestinal bacterial overgrowth in rosacea: Clinical effectiveness of its eradication [J].
Parodi, Andrea ;
Paolino, Stefania ;
Greco, Alfredo ;
Drago, Francesco ;
Mansi, Carlo ;
Rebora, Alfredo ;
Parodi, Aurora ;
Savarino, Vincenzo .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (07) :759-764
[3]   Restless legs syndrome and periodic limb movement disorder [J].
Rama, AN ;
Kushida, CA .
MEDICAL CLINICS OF NORTH AMERICA, 2004, 88 (03) :653-+
[4]   Experimental and clinical pharmacology of rifaximin, a gastrointestinal selective antibiotic [J].
Scarpignato, C ;
Pelosini, I .
DIGESTION, 2006, 73 :13-27
[5]   Restless legs syndrome in patients with irritable bowel syndrome: Response to small intestinal bacterial overgrowth therapy [J].
Weinstock, Leonard B. ;
Fern, Steve E. ;
Duntley, Stephen P. .
DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (05) :1252-1256